Insmed (NASDAQ:INSM) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Insmed missed estimated earnings by 5.56%, reporting an EPS of $-0.95 versus an estimate of $-0.9.
Revenue was up $14.71 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1, which was followed by a 1.89% increase in the share price the next day.
Here's a look at Insmed's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.86 | -0.85 | -0.88 | -0.7 |
| EPS Actual | -0.96 | -0.91 | -0.89 | -1 |
| Revenue Estimate | 49.23M | 43.72M | 41.64M | 41.44M |
| Revenue Actual | 46.76M | 45.37M | 40.21M | 41.41M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
